Janus Henderson Investors US’s Achillion Pharmaceuticals ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$18.5M Sell
4,392,988
-265,857
-6% -$1.1M 0.02% 617
2016
Q4
$19.2M Sell
4,658,845
-993,649
-18% -$5.28M 0.02% 622
2016
Q3
$45.8M Sell
5,652,494
-59,865
-1% -$509K 0.04% 435
2016
Q2
$44.6M Sell
5,712,359
-1,066,645
-16% -$9.15M 0.04% 445
2016
Q1
$52.3M Sell
6,779,004
-238,461
-3% -$1.75M 0.05% 420
2015
Q4
$75.7M Sell
7,017,465
-317,083
-4% -$2.88M 0.06% 329
2015
Q3
$50.7M Buy
7,334,548
+902,220
+14% +$7.35M 0.05% 413
2015
Q2
$57M Buy
6,432,328
+1,803,126
+39% +$17.1M 0.05% 422
2015
Q1
$45.6M Buy
4,629,202
+1,525,833
+49% +$19.1M 0.04% 468
2014
Q4
$38M Sell
3,103,369
-508,610
-14% -$6.21M 0.03% 498
2014
Q3
$36M Buy
+3,611,979
New +$33.5M 0.03% 486
2013
Q4
Sell
-2,410,741
Closed -$7.28M 1122
2013
Q3
$7.28M Buy
2,410,741
+11,878
+0.5% +$81.4K 0.01% 694
2013
Q2
$19.6M Buy
+2,398,863
New +$18.3M 0.02% 503

Other funds holding ACHN